Complement and microglia mediate early synapse loss in Alzheimer mouse models
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index; 21 of the 28 sources its claims cite were checked for support.
Abstract
Too much cleaning up: The complement system and microglia seek out and destroy unwanted cellular debris for the peripheral immune system as well as excess synapses in the developing brain. Hong et al. now show how the system may go haywire in adults early in the progression toward Alzheimer's disease (AD). Aberrant synapse loss is an early feature of Alzheimer's and correlates with cognitive decline. In mice susceptible to AD, complement was associated with synapses, and microglial function was required for synapse loss. The authors speculate that aberrant activation of this “trash disposal” system underlies AD pathology. Science , this issue p. 712
Overview
CoChat Summary
TL;DR
In Alzheimer mouse models, classical complement proteins C1q and C3 increase and localize to synapses before plaques, and blocking C1q, C3, or microglial CR3 reduces early synapse loss. Soluble Aβ oligomers drive microglial engulfment of synaptic material through a CR3-dependent pathway, suggesting reactivation of developmental synaptic pruning in early AD.
Key findings
- J20 hAPP mice showed significant hippocampal synapse loss at 3–4 months, before plaque deposition; loss occurred in CA1, CA3, and dentate gyrus at 3 months but not in striatum, and was not seen at 1 month.
- C1q was elevated in J20 brains as early as 1 month, region-specifically in hippocampus and frontal cortex, and colocalized with PSD95-positive puncta; Compound E reduced soluble Aβ and C1q deposition, while oligomeric Aβ—but not monomeric Aβ or vehicle—induced C1q deposition and synaptic colocalization.
- Oligomeric Aβ induced synapse loss within 72 h in WT mice but not in C1qa knockout mice; anti-C1q antibody ANX-M1 prevented oAβ-induced synapse loss and LTP impairment, and APP/PS1xC3 KO mice did not show the synapse loss seen in 4-month APP/PS1 hippocampus.
- Microglial CD68 increased in J20 hippocampus and after oAβ; oAβ increased internalized Homer-GFP in microglia, failed to do so in CR3 KO mice, and induced hippocampal synapse loss in WT but not CR3 KO mice.
Methods
- Mouse models included J20 hAPP, APP/PS1, C1qa KO, C3 KO, CR3 KO, and Homer-GFP mice, with WT littermates and ages including 1 month, 3–4 months, and P21.
- Synapse quantification used super-resolution structured illumination microscopy, confocal imaging, and electron microscopy with colocalized pre- and postsynaptic puncta markers including synaptophysin/PSD95, synaptotagmin/homer, and synapsin/PSD95; C1q and C3 colocalization with PSD95 was also measured.
- Interventions included Compound E, intracerebroventricular or tail vein injections of soluble Aβ oligomers, monomers, or vehicle, anti-C1q antibody ANX-M1 or IgG control, acute hippocampal slice LTP recordings, and an in vivo synaptic engulfment assay.
Limitations
- The paper states that specific synaptic C1q receptors are not yet known and that oAβ and C1q may act indirectly through cytokines such as TGFβ, microglial or astrocytic activation, or other pathways including MHCI/PirB.
- The paper states that the complement pathway may not be involved in all pathological routes to AD, including plaque-associated synapse loss, and that future studies are needed to examine plaque-associated synapse loss and other synaptopathies such as tauopathies and Huntington’s disease.
- Evident from the text: the findings are from mouse models and acute hippocampal slices, not human AD tissue or clinical trials, and the study focuses on early pre-plaque mechanisms rather than established plaque-associated neuropathology.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Valid · 0 Not valid · 2 Not checked · 48 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [5] Stevens B The classical complement cascade mediates CNS synapse elimination. Cell 2007 131 1164 1178 18083105 source
The Results report C1q localized to synapses in the developing dLGN during synaptic pruning and relocalized to adult retinal synapses in early glaucoma, before significant synapse loss. The Discussion likewise places synaptic C1q relocalization before or concurrent with synapse loss in the glaucoma model. (LLM, conf=0.89)
- Not checked — no full text of the sourcecites [27] Stephan AH Barres BA Stevens B The complement system: an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci 2012 35 369 389 22715882 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“suggesting that the engulfed synapses are internalized into lysosomal compartments in a manner similar to developmental synaptic pruning (6).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [6] Schafer DP Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner. Neuron 2012 74 691 705 22632727 PMC3528177 source
The Results section, “Microglia engulf RGC inputs during a period of active synaptic pruning” (page unavailable), reports that most engulfed RGC inputs colocalized with microglial lysosomal compartments. The Results section, “Microglia engulf presynaptic elements specific to RGCs” (page unavailable), also identifies an RGC presynaptic marker within microglial lysosomes, supporting the proposed similarity to developmental synaptic pruning. (LLM, conf=0.94)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Quantification of colocalized pre- and postsynaptic puncta (synaptophysin and PSD95 (Fig. 1A); synaptotagmin and homer (figs. S1A-D)) revealed a significant loss of synapses in J20 hippocampus at 3-4 months old (mo), an age that precedes plaque deposition (11, 12).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [11] Mucke L High-Level Neuronal Expression of Abeta 1-42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation. Journal of Neuroscience 2000 20 4050 10818140 PMC6772621 source
The citation is attached to the statement that 3–4 months precedes plaque deposition, not to the citing authors’ synapse measurements. In “Effects of hAPP mutations on formation of amyloid plaques” (Fig. 4; page not provided), the paper assesses mice at 2–4 months and reports amyloid deposition in APP Sw,Ind mice at 5–7 months; the paper identifies J20 as an APP Sw,Ind line. (LLM, conf=0.91)
- Supportedcites [12] Hong S Dynamic Analysis of Amyloid -Protein in Behaving Mice Reveals Opposing Changes in ISF versus Parenchymal A during Age-Related Plaque Formation. Journal of Neuroscience 2011 31 15861 15869 22049429 PMC3227224 source
The citation follows the statement that 3–4 months precedes plaque deposition, rather than the citing authors’ own synapse measurements. The Results section (page unavailable) identifies approximately 3-month-old J20 mice as pre-plaque and describes 3–7-month-old mice as plaque-free. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Genome-wide association studies (GWAS) implicate microglia and complement-related pathways in AD (1).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [1] Hong S Dissing-Olesen L Stevens B New insights on the role of microglia in synaptic pruning in health and disease. Curr Opin Neurobiol 2016 doi:10.1016/j.conb.2015.12.004 PMC5479435 26745839 source
The Introduction says GWAS and integrated network studies identify immune-related AD risk pathways implicating microglia. The section on microglia–synapse dysfunction identifies GWAS variants CLU and CR1, both related to complement. Page numbers are not provided in our copy. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“C1q was also similarly increased in hippocampus of another model of AD, the APP/PS1 mice (15) (Fig. S2C).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [15] Jankowsky JL Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet 2004 13 159 170 14645205 source
The citation identifies the APP/PS1 mouse model, while the citing document points to its own Fig. S2C for the C1q increase. Figure 2 (p. 4) describes APPswe/PS1 double-transgenic mice and shows hippocampal amyloid pathology in that model. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
48 more claims · 5 with their cited sources checked
Create a free account to see all 66 claims and every source verdict.
- It may state two separate claims as one. 11
- Probably not a substantial claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“increasing evidence demonstrate that immune signaling may not just be a consequence of protein aggregation in the brain, but that it actually causes the buildup of aggregates at the earliest stages of the disease process.15–17”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [15]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In neurodegeneration, the complement pathway is activated, and inhibiting the complement proteins C1q or C3 results in less neuroinflammation, Aβ plaques and synapse loss29,30.”
From Exercise plasma boosts memory and dampens brain inflammation via clusterin (2021) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Before the onset of Aβ deposition, microglia engulf synapses opsonized with the complement factors C1q and C3 upon CR3-mediated recognition of C3 (121).”
From Microglia in Alzheimer's disease (2017) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lack of C1q, C3, or CR3 curbed microglia activation and synaptic loss during amyloid plaque deposition.”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [139]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Inappropriate control of the classical complement cascade causes unresolvable inflammation and disease (Hong et al. , 2016; Hansen, Hanson and Sheng, 2018; Morgan, 2018).”
From Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer’s Disease (2020) · cites this paper as Hong et al., 2016
Experimental — accuracy not yet measured
70 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Cited work 10.1038/nn.3560 · retracted 2022-01-13 · notice 10.1038/s41593-021-00877-7 · this paper published 2016-05-06
Citations
Cites
1 retracted
Bialas, A. R., & Stevens, B. (2013) · Nature Neuroscience · doi:10.1038/nn.3560 · Cited by 519 · cited 2×
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Self-citationRetractedAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · cited 1×
“Synaptic deficits occur in early AD and mild cognitively impaired patients before onset of plaques and are some of the first signs of the neuronal degenerative process (4, 23-25).”
Self-citationTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Self-citationThe Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313 · cited 4×
“Although specific receptors for C1q at synapses are not yet known, C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
InfluentialSelf-citationIdentification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543 · cited 1×
“S11), indicating they are resident cells (22).”
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856 · cited 3×
“S4), long before Aβ plaques deposit (11, 12), raising the question of whether C1q increase in these pre-plaque brains is dependent on soluble Aβ levels.”
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Cited by
Items 1,901–2,000 of 3,349
Microglial contribution to synaptic uptake in the prefrontal cortex in schizophrenia
Tzioras, M., Stevenson, A. J., Boche, D., & Spires‐Jones, T. L. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12660 · Cited by 11
Brain transcriptome analysis of a CLN2 mouse model as a function of disease progression
Domowicz, M. S., Chan, W., Vázquez, P. N. C., Gonzalez, T., & Schwartz, N. B. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02302-z · Cited by 12
Grover, A., Sankaranarayanan, S., Mathur, V., Suri, P., Qiu, H., Andrews-Zwilling, Y. S., Mease, K. M., Taylor, L. K., Cahir-McFarland, E. D., Keswani, S. C., et al. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.2.3 · Cited by 14
“5,6,26 The blockade of C1q prevents recruitment and activation of all downstream components within the classical pathway, including C4, C3, and C5, that drive a local immune response and tissue destruction in the retina.”
BackgroundMolecular mechanisms that change synapse number
Mansilla, A., Jordán-Álvarez, S., Santana, E., Jarabo, P., Casas‐Tintó, S., & Ferrús, A. (2018) · Journal of Neurogenetics · doi:10.1080/01677063.2018.1506781 · Cited by 13
“Experimental inhibition of C1q, the trigger of the classical complement cascade, C3, or the microglial complement receptor CR3 reduces the number of phagocytic microglia, as well as the extent of synapse loss in an Alzheimer’s disease mouse model (Hong et al., 2016).”
BackgroundSystems genetics identifies modifiers of Alzheimer’s disease risk and resiliencePreprint
Neuner, S. M., Hohman, T. J., Richholt, R., Bennett, D. A., Schneider, J. A., Jager, P. L. D., Huentelman, M. J., O’Connell, K. M. S., & Kaczorowski, C. C. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/225714 · Cited by 11
“In addition, the effect of the 5XFAD transgene significantly altered the expression of genes known to be misregulated in AD, particularly Bin1, Cd33, Clu (Karch et al., 2012), Trem2 (Piccio et al., 2016), and C1qa (Hong et al., 2016), Figure 1F.”
BackgroundMans, R. A., Kelehear, H., Rotschafer, S. E., Ganas, C., Uche-Moon, B., Call, G., Mauersberg, C. C., Toller, J., & Diamanduros, A. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1563086 · Cited by 10
Wang, H., Lim, J. J., Gu, H., Xia, Z., & Cui, J. Y. (2025) · Toxicology · doi:10.1016/j.tox.2025.154265 · Cited by 14
Sabbagh, M. N., Cummings, J. L., Ballard, C. G., van der Flier, W. M., Heneka, M. T., Holst, J. J., Knudsen, L. B., Salloway, S., Tansey, M. G., & Drucker, D. J. (2025) · Nature Aging · doi:10.1038/s43587-025-01029-3 · Cited by 17
“When stimulated by Aβ, microglia-derived complement factor 3 can mark synapses, which are subsequently removed in excess 14 ; in some cases, microglia can remove entire neurons 13 .”
Therapeutic targeting of neuroimmune mechanisms in neurodegeneration
Monroe, K. M., Hong, S. Y., Lewcock, J. W., & Yang, A. C. (2026) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01370-7 · Cited by 16
Self-citationMicroglia–Neuron Crosstalk: An Intimate Molecular Conversation in Neurodegeneration
Wang, S., Wang, S., Hongzhuan, C. H. E. N., & Xu, J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27042011 · Cited by 13
“Inhibition of C1q, C3, or CR3 markedly attenuates early synaptic pathology [121].”
Activity-Dependent Synapse Refinement: From Mechanisms to Molecules
Nagappan-Chettiar, S., Burbridge, T. J., & Umemori, H. (2023) · The Neuroscientist · doi:10.1177/10738584231170167 · Cited by 13
“…and abnormal signaling of the molecules that govern synapse refinement have been implicated in several neurodevelopmental and neurodegenerative disorders characterized by aberrant synapse numbers (Hong and others 2016; Penzes and others 2011; Sellgren and others 2019; Tang and others 2014).”
Immune activation of the p75 neurotrophin receptor: implications in neuroinflammation
Danelon, V., Garrett-Thomson, S. C., Almo, S. C., Lee, F. S., & Hempstead, B. L. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1305574 · Cited by 12
“In mouse models of Alzheimer’s Disease and frontotemporal dementia (FTD), C3 and C1q associate with synapses, and microglia recognize and engulf these synapses in a CR3 (complement receptor 3)-dependent manner (Hong et al., 2016).”
BackgroundSingle-Cell RNA-seq reveals transcriptomic modulation of Alzheimer’s disease by activated protein C
Fatmi, M. K., Wang, H., Slotabec, L. A., Wen, C., Seale, B. C., Zhao, B., & Li, J. (2024) · Aging · doi:10.18632/aging.205624 · Cited by 12
“Though inhibition of C1q has known to reduce the number of microglia [31, 32], C1q likely is not solely involved in microglial reduction due the expression level of C1q not exceedingly changing APC treated microglia.”
BackgroundPhotodynamic Therapy under Diagnostic Control of Wounds with Antibiotic-Resistant Microflora
Shiryaev, A., Ivankov, M., Voitova, A. V., Kalyagina, N. A., Efendiev, K. T., Pisareva, T., Zavodnov, S., Reshetov, I. V., & Loschenov, V. B. (2024) · Photonics · doi:10.3390/photonics11070594 · Cited by 13
Wu, X., Liu, M., Zhang, X., Pan, X., Cui, X., Jin, J., Sun, H., Xiao, C., Tong, X., Ren, L., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-67537-1 · Cited by 14
“The focus on microglial alterations is paramount, given their pivotal role in responding to the accumulation of Aβ plaques and neurofibrillary tangles, the hallmark features of AD 21,22 .”
BackgroundGazzar, W. B. E., Farag, A. A., Samir, M., Bayoumi, H., Youssef, H. S., Marei, Y. M., Mohamed, S. K., Marei, A. M., Abdelfatah, R. M., Mahmoud, M. M., et al. (2024) · BioFactors · doi:10.1002/biof.2107 · Cited by 14
Mechanistic Approach to Immunity and Immunotherapy of Alzheimer’s Disease: A Review
Islam, M. R., Rabbi, M. A., Hossain, T., Sultana, S., & Uddin, S. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00360 · Cited by 16
Immune cells in Alzheimer’s disease: insights into pathogenesis and potential therapeutic targets
Fu, X., Cai, H., Quan, S., Ren, Z., Xu, Y., & Jia, L. (2024) · Medical Review · doi:10.1515/mr-2024-0064 · Cited by 11
“However, the persistent presence of plaques leads to the continuous production of in fl ammatory cytokines, chemokines, and neuro-toxins, ultimately damaging neurons and other cells including microglia, astrocytes, and oligodendrocytes [9, 10].”
Microglial Responses to Alzheimer's Disease Pathology: Insights From “Omics” Studies
Reid, A. N., Jayadev, S., & Prater, K. E. (2025) · Glia · doi:10.1002/glia.24666 · Cited by 11
“Additionally, genes associated with the complement pathway ( C1qa , C3ar , C4b , Itgam , and Itgb2 ) were found to be upregulated in the bulk tissue, corroborating findings from other AD mouse models (Castillo et al. 2017; Hong et al. 2016).”
Belančić, A., Janković, T., Gkrinia, E. M. M., Kristić, I., Bumber, J. R., Rački, V., Pilipović, K., Vitezić, D., & Mršić‐Pelčić, J. (2025) · Neurology International · doi:10.3390/neurolint17030041 · Cited by 15
“The key initiator is known as C1q, and there are in vivo studies that show the inhibition of this initiation leads to a rescue of synapses in SMA mice [93] and plays a key role in maintaining functional motor circuits [119].”
Targeting necroptosis in Alzheimer’s disease: can exercise modulate neuronal death?
Lu, D., Zhang, W., Li, R., Tan, S., & Zhang, Y. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1499871 · Cited by 13
“In AD, microglia exhibit two distinct phenotypes: the M1 pro-inflammatory phenotype, which exacerbates neuroinflammation and causes neuronal damage (Neniskyte et al., 2016), and the M2 anti-inflammatory phenotype, activated by IL-4 or IL-10, which aids in A β clearance (Hong et al., 2016).”
Hay, A. J. D., Popichak, K. A., Mumford, G., Shirley, P. M., Bian, J., Wolfrath, L., Lei, S., Eggers, M., Nicholson, E. M., Tjalkens, R. B., et al. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1012582 · Cited by 14
Miles, L. A., & Masters, C. L. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251361049 · Cited by 12
“42 We reported the 2.4 Å structure of sola-nezumab bound to A β 12 − 28 (N-V 12 HHQKLVFFAED VGSNK28).”
InfluentialLi, F., Luo, Q., Guo, T., Zhou, S., Cheng, Z., Pan, H., & Tu, J. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2561789 · Cited by 19
“For instance, in neurodegenerative disorders, such as AD [60] and PD [61], microglia actively clear misfolded proteins (e.g. pTau, α -synuclein), apoptotic cells, A β deposits (through phagocytosis and compaction), and damaged synapses.”
Neuroinflammation als Motor der Alzheimer-Erkrankung
Castro‐Gomez, S., Binder, J., & Heneka, M. T. (2019) · Der Nervenarzt · doi:10.1007/s00115-019-0778-3 · Cited by 17
Kartalou, G.-I., Endres, T., Leßmann, V., & Gottmann, K. (2020) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2020.108797 · Cited by 16
Wang, Q., Ishizawa, K., Li, J., Fujii, W., Nemoto, Y., Yamazaki, O., Tamura, Y., Miura, Y., Nie, X., Abe, R., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-01298-1 · Cited by 13
Mengr, A., Hrubá, L., Exnerová, A., Holubová, M., Popelová, A., Železná, B., Kuneš, J., & Maletínská, L. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666210922110652 · Cited by 12
Li, Z., Zhang, W., Gao, F., Tang, Q., Kang, D., & Shen, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.810335 · Cited by 10
Liang, F., Sun, F., He, B., & Wang, J. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.03.043 · Cited by 13
Microglia: Rheostats of space radiation effects in the CNS microenvironment
Kerry O'Banion, M. (2022) · Life Sciences in Space Research · doi:10.1016/j.lssr.2022.08.002 · Cited by 10
Ju, W.-Y., Wang, Q., Song, L.-J., Ding, Z., Li, X., Kumar, G., Yan, Y., & Ma, C. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07968-z · Cited by 12
Alia, A. O., Jeon, S., Popović, J., Salvo, M. A., Sadleir, K. R., Vassar, R. J., & Cuddy, L. K. (2022) · Scientific Reports · doi:10.1038/s41598-022-26671-4 · Cited by 12
Xu, Y., MOULDING, D. A., Jin, W., & Beggs, S. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.04.001 · Cited by 9
“Previous studies on microglial engulfment in adulthood have either focused on excitatory synapses or used pan-synaptic markers that do not distinguish between excitatory and inhibitory synapses (Hong et al., 2016; Shi et al., 2015; Stevens et al., 2007; Wang et al., 2020), potentially missing synapse-specific interact…”
BackgroundReduced levels of NGF shift astrocytes toward a neurotoxic phenotype
Tiberi, A., Carucci, N. M., Testa, G., Rizzi, C., Pacifico, P., Borgonovo, G., Arisi, I., D’Onofrio, M., Brandi, R., Gan, W., et al. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1165125 · Cited by 10
Molecular signaling from microglia impacts macroglia autophagy and neurons survival in glaucoma
Yu, H., Zhong, H., Sun, J. Y., Li, N., Chen, J., Shen, B., Huang, P. C., Shen, X. P., Huang, S., & Zhong, Y. (2023) · iScience · doi:10.1016/j.isci.2023.106839 · Cited by 10
Maksour, S., & Ooi, L. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15885 · Cited by 13
Pumo, A., & Legeay, S. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148817 · Cited by 14
“A recent study have reported that in mouse models of amyloidosis, there is an abnormal reactivation of microglial synaptic pruning leading to early synapse loss and dysfunction in a complement-dependent manner (Hong et al., 2016).”
InfluentialGenetic ablation of neuronal mitochondrial calcium uptake impedes Alzheimer’s disease progression
Jadiya, P., Berezhnaya, E. V., Kolmetzky, D. W., Tomar, D., Cohen, H. M., Shukla, S., Thomas, M., Khaledi, S., Garbincius, J. F., Kennedy, L., et al. (2026) · The EMBO Journal · doi:10.1038/s44318-026-00809-w · Cited by 13
“Increased oxidative stress, neuroin fl ammation, and synaptic dysfunction are early cellular occurrences in AD pathogenesis (Butter fi eld and Boyd-Kimball, 2018; Hong et al, 2016).”
Headmasters: Microglial regulation of learning and memory in health and disease
Weinhard, L., d’Errico, P., & Tay, T. L. (2018) · AIMS molecular science · doi:10.3934/molsci.2018.1.63 · Cited by 12
“Genetic or pharmacological depletion of C1q in the AD models could arrest the loss of PSD95 puncta and rescue LTP in acute hippocampal slices [161].”
Liu, Y., Zhang, P., Zheng, Y., Yang, C., Du, T., Ge, M., Chang, X., Duan, R., & Ma, G. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2622-8 · Cited by 10
Clare, A. J., Day, R. C., Empson, R. M., & Hughes, S. M. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00410 · Cited by 12
Meox2 Haploinsufficiency Accelerates Axonal Degeneration in DBA/2J Glaucoma
Buchanan, R. A., Foley, K. E., Pepper, K. W., Reagan, A. M., Keezer, K. J., Hewes, A. A., Diemler, C. A., Preuß, C., Soto, I., John, S. W. M., et al. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-26126 · Cited by 12
“For instance, in Alzheimer’s Disease, microglia may execute a beneficial response to clear amyloid(78) but also aberrantly prune synapses.(79) Multiple studies are now using single-cell profiling approaches to define subtypes of microglia and other myeloid cells (monocytes/macrophages) to develop strategies to target…”
BackgroundJorge, M. S., & Bugiani, M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9913-8_9 · Cited by 11
Eid, R. S., Lieblich, S. E., Wong, S. J., & Galea, L. A. M. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100199 · Cited by 11
A Destruction Model of the Vascular and Lymphatic Systems in the Emergence of Psychiatric Symptoms
Segawa, K., Blumenthal, Y., Yamawaki, Y., & Ohtsuki, G. (2021) · Biology · doi:10.3390/biology10010034 · Cited by 13
Wickstead, E. S., Irving, M. A., Getting, S. J., & McArthur, S. (2021) · FEBS Journal · doi:10.1111/febs.15861 · Cited by 11
Hu, H., Ma, L., Hu, H., Bi, Y., Ma, Y., Shen, X., Ou, Y., Dong, Q., Tan, L., & Yu, J. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00383-5 · Cited by 11
WS635 Attenuates the Anesthesia/Surgery-Induced Cognitive Impairment in Mice
Lin, J., Shen, F., Lü, J., Liang, F., Zhang, Y., Xie, Z., & Dong, Y. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.688587 · Cited by 10
“WS635 was shown to be orally or intravenous bioavailable in multiple animal species (rat and monkey) and produced blood and liver concentrations of parent drug that exceeded the 50% effective dose determined in the bicistronic con1b-derived replicon assay (Hopkins et al., 2010).”
BackgroundInfluentialHuman blood serum proteome changes after 6 hours of sleep deprivation at night
Bjørkum, A. A., Durán, A. C., Berven, F. S., Roy, D. S., Rosendahl, K., Birkeland, E., & Stuhr, L. E. B. (2021) · Sleep Science and Practice · doi:10.1186/s41606-021-00066-2 · Cited by 10
“Also C1q is assumed to be a C3independent key mediator of age-related cognitive impairment (Hong et al., 2016) and where C1q, C3 and CR3 contributes towards an increased synapse loss in Alzheimer disease and memory consolidation (Ferreira et al., 2019).”
BackgroundQuantifying Glial-Glial Tiling Using Automated Image Analysis in Drosophila
Salazar, G., Ross, G., Maserejian, A., & Coutinho‐Budd, J. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.826483 · Cited by 8
“Glial tiling is a phenomenon that occurs throughout the animal kingdom (Oberheim et al., 2009; Hughes et al., 2013; Kettenmann et al., 2013; Stork et al., 2014; Nichols et al., 2018), yet we still know relatively little about the formation, maintenance, and function of glial domains.”
BackgroundGaraschuk, O. (2017) · e-Neuroforum · doi:10.1515/nf-2016-a057 · Cited by 10
“They showed that the classical complement cascade-mediated pathways, which normally contribute to synaptic pruning of excess synapses during early postnatal development, cause engulfment and elimination of synapses by microglia in the amyloid-depositing brain (Hong et al., 2016).”
BackgroundLoss of NPC1 enhances phagocytic uptake and impairs lipid trafficking in microgliaPreprint
Colombo, A. V., Dinkel, L., Müller, S. A., Monasor, L. S., Schifferer, M., Cantuti‐Castelvetri, L., König, J., Vidatic, L., Brémovà-Ertl, T., Hecimovic, S. K., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/789511 · Cited by 10
Tijms, B. M., Vromen, E. M., Mjaavatten, O., Holstege, H., Reus, L. M., van der Lee, S., Wesenhagen, K. E., Lorenzini, L., Vermunt, L., Venkatraghavan, V., et al. (2023) · doi:10.1101/2023.05.10.23289793 · Cited by 10
Alexander, K. D., Ramachandran, S., Biswas, K., Lambert, C. M., Russell, J., Oliver, D. B., Armstrong, W., Rettler, M., Liu, S., Doitsidou, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43281-4 · Cited by 9
“Indeed, recent work has suggested intriguing parallels between the elimination of synapses during development and neurodegenerative processes during disease 10 – 13 .”
BackgroundAmyloid-β-driven Alzheimer’s disease reshapes the colonic immune system in mice
Makhijani, P., Valentino, T. R., Manwaring-Mueller, M., Emani, R., Mu, W., Aguirre, C. G., Tan, C. R., Rane, A., Wilson, K. A., Kifle, A., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116109 · Cited by 16
“7 However, chronic activation of certain microglial subtypes promotes neurodegeneration by orchestrating synapse loss, 8 blood-brain barrier (BBB) breakdown, 9,10 tau seeding, 11 and infiltration of cytotoxic T cells.”
Liu, Y., Jiang, Q., Huang, Y., Zhang, X., Kang, H., Yu, C., Xia, Y., Liu, Y., & Zhang, H. (2025) · Cells · doi:10.3390/cells14221780 · Cited by 10
“A prominent hypothesis in the current scientific community posits that microglia-mediated chronic neuroinflammation is the core mechanism underlying a series of neurological symptoms (e.g., brain fog, fatigue) in Long COVID [152].”
He, A., Wang, Y., Shen, Y., Dong, Z., Luo, L., Ge, X., Liu, X., Mao, Y., Zhang, T., Li, X., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-01028-4 · Cited by 12
“https://doi.org/10.1038/s43587-025-01028-4 a selective synapse loss in the brain of AD 60,61 .”
InfluentialBasic Microglial Functions and How They Go Awry in Neurodegenerative Disease
McKinney, J. E., Bennett, M. L., & Bennett, F. C. (2026) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-042624-114332 · Cited by 16
Kusui, Y., Izuo, N., Reika, T., Asano, T., & Nitta, A. (2024) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2023.12.003 · Cited by 14
Sawabe, A., Okazaki, S., Nakamura, A., Goitsuka, R., & Kaifu, T. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae009 · Cited by 9
Wei, H.-R., Tang, L. F., Yang, X., Chen, C., Li, L.-X., Mao, Y., Wang, D., Kang, F., Qun, S., Zhang, Z., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113804 · Cited by 10
Lefebvre, C., Vreulx, A.-C., Dumortier, C., Bégard, S., Gelle, C., Siedlecki‐Wullich, D., Colin, M., Kilinc, D., & Halliez, S. (2024) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c00997 · Cited by 10
Zhang, C., Shi, G., Meng, Q., Hu, R., Yang, L., Hu, G., Wang, K., & Huang, M. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.134607 · Cited by 11
Barros‐Aragão, F. G. Q., Pinto, T. P., Carregari, V. C., Braga, N., Pinheiro, T., Reis‐de‐Oliveira, G., Queiroz, D. C., Fonseca, P. L. C., Gonçalves, A. L., Cabral‐Castro, M. J., et al. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100805 · Cited by 11
Wang, J., Zhang, B., Li, L., Tang, X., Zeng, J., Song, Y., Xu, C., Zhao, K., Liu, G., Lu, Y., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01446 · Cited by 10
“It has been reported that the complement system plays a vital role in neurodegenerative diseases that appear to involve a long-lasting inflammatory response (Hong et al., 2016; Liddelow et al., 2017).”
BackgroundLi, M., Guan, M., Lin, J., Zhu, K., Zhu, J., Guo, M., Li, Y., Chen, Y., Chen, Y., Zou, Y., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14046 · Cited by 13
“41,42,72 C1QA is a subunit of serum complement subcomponent C1q.”
Rapid phagosome isolation enables unbiased multiomic analysis of human microglial phagosomes
Wogram, E., Sümpelmann, F., Dong, W., Rawat, E. S., Fernández-Maestre, I., Fu, D., Braswell, B., Khalil, A. S., Buescher, J. M., Mittler, G., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.07.019 · Cited by 12
Sun, P., Liao, S., Sang, P., Liu, M., & Yang, J.-B. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e36705 · Cited by 15
“Recent research evidence that disruption of microglia function leads to delayed maturation of synaptic circuits in the hippocampus [65 – 68].”
BackgroundVecchiarelli, H. A., Lopes, L. T., Paolicelli, R. C., Stevens, B., Wake, H., & Tremblay, M. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_11 · Cited by 10
Self-citationKim, N., Choi, H., Kim, U., Kim, S., Kim, Y. B., & Shin, H. Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179451 · Cited by 11
“In Alzheimer’s mouse models, activated microglia engage in synaptic phagocytosis, a process dependent on complement factors like C3, C1q, and CR [33].”
BackgroundMicroglia either promote or restrain TRAIL-mediated excitotoxicity caused by Aβ1−42 oligomers
Zou, J., McNair, E. M., DeCastro, S., Lyons, S. P., Mordant, A. L., Herring, L. E., Vetreno, R. P., & Coleman, L. G. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03208-2 · Cited by 14
Daskoulidou, N., Carpanini, S. M., Zelek, W. M., & Morgan, B. P. (2024) · Current topics in behavioral neurosciences · doi:10.1007/7854_2024_524 · Cited by 12
Neuroimaging Findings of Psychosis in Alzheimer's Disease: A Systematic Review
Nabizadeh, F., Sheykhlou, S., Mahmoodi, S., Khalili, E., Zafari, R., & Hosseini, H. (2024) · Brain and Behavior · doi:10.1002/brb3.70205 · Cited by 11
Arosio, B., Rossi, P. D., Ferri, E., Consorti, E., Ciccone, S., Lucchi, T. A., & Montano, N. (2025) · Experimental Gerontology · doi:10.1016/j.exger.2025.112692 · Cited by 9
“…2016; Shaftel et al., 2007), supporting the dual role of activated microglia in the pathogenesis of AD, namely the beneficial one consisting of phagocytosis and the detrimental one inducing a chronic increase in cytokine levels (Haruwaka et al., 2019; Hong et al., 2016; Schafer and Stevens, 2015).”
Rodríguez-López, A., Esteban, D., Domínguez‐Romero, A. N., & Gevorkian, G. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115189 · Cited by 9
Retinal and thalamic alterations in the 5xFAD mouse model of Alzheimer’s disease
McCool, S., SMITH, J., Sladek, A. L., Fan, S., & Hook, M. J. V. (2025) · PLoS ONE · doi:10.1371/journal.pone.0319397 · Cited by 9
“In AD, rogue synaptic pruning divergent from homeostatic synaptic maintenance takes place and is responsible, at least in part, for the loss of synapses including microglia-mediated synaptic pruning [32].”
Wang, Y., Liu, Z., & Ma, X. (2025) · Genome Medicine · doi:10.1186/s13073-025-01449-1 · Cited by 12
“…analysis between disease and normal domain identify DEGs that are significantly enriched with gliogenesis and glial cell differentiation, which are associated with neuro-degenerative diseases in brain regions [74] (gene-ontology enrichment analysis, hypergeometric test, Additional file 1: Fig.”
Zayed, M., Kim, Y., & Jeong, B. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04273-x · Cited by 11
“Those upregulated genes are associated with reactive astrocytes [45, 65].”
The regulation of microglia by aging and autophagy in multiple sclerosis
Wang, X., Sun, Y., Yu, H., Xue, C., Pei, X., Chen, Y., & Guan, Y. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107786 · Cited by 11
Molecular hydrogen therapy: A “democratic” emerging strategy against aging and age-related diseases
Brandi, G., Delbaldo, C., Deserti, M., Relli, V., Rimedio, S., Palloni, A., Deiana, C., Saccoccio, G., Ingenito, R., & Tavolari, S. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102802 · Cited by 11
Cell autonomous microglia defects in a stem cell model of frontotemporal dementia tau
Iyer, A. K., Vermunt, L., Mirfakhar, F. S., Minaya, M., Acquarone, M., Koppisetti, R. K., Renganathan, A., You, S., Danhash, E., Schache, K. J., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03073-2 · Cited by 16
Garcia, C., Banerjee, A., Montgomery, C. B., Adcock, L., Maezawa, I., Ramsey, J. J., Grodzki, A. C., Kim, K., & Cortopassi, G. A. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1628835 · Cited by 10
“Thus, as microglia control synaptic plasticity and memory formation (Hong et al., 2016; Vanderheyden et al., 2018; Brucato and Benjamin, 2020), and respond to lipids and their derivatives, which include ketones (Wang Y. et al., 2015), it is our hypothesis that BHB, through its…”
Tabassum, N. I., Selvaraji, S., Fan, Y., Lim, V. J. T., Cheng, X., Peng, X., Arora, A., Rajeev, V., Ratcliffe, J., Johnson, C. J., et al. (2025) · Theranostics · doi:10.7150/thno.119422 · Cited by 21
“Recent studies have identified complement-dependent phagocytosis of synapses by activated microglia as a key mechanism in other neurodegenerative diseases [6], but whether similar processes operate in VaD remains unknown.”
Glia Preserve Their Own Functions While Compensating for Neighboring Glial Cell Dysfunction
Beachum, A. N., Salazar, G., Nachbar, A., Krause, K., Klose, H., Meyer, K., Maserejian, A., Ross, G., Boyd, H., Weigel, T. K., et al. (2025) · Glia · doi:10.1002/glia.70072 · Cited by 13
“Glia play active roles in setting up and maintaining the nervous system, including ongoing sculpting of the nervous system throughout development, maintenance, and disease (MacDonald et al. 2006; Hong et al. 2016; Schafer et al. 2016; McLaughlin et al. 2019; Werneburg et al. 2020).”
Glial reactivity and cognitive decline follow chronic heterochromatin loss in neurons
Newman, A. G., Sharif, J., Bessa, P., Zaqout, S., Brown, J., Richter, D., Dannenberg, R., Nakayama, M., Mueller, S. G., Schaub, T., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61319-7 · Cited by 12
“HP1 β / γ DKO hippocampi exhibit a ‘ pre-plaque ’ state similarto that found in very old hippocampi and in early Alzheimer ’ s disease, where complement seeding, microglial activation and synapse loss precede plaque pathology 57 .”
Lenoël, I., Ribon, M., Lorenc, F., Diebold, A., Philibert, C. E., Robaldo, D., Badsi, M., Perronnet, J., Lameth, J., Berriat, F., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63211-w · Cited by 12
“A possible downstream consequence of microglial defects could be deregulated synaptic pruning 53 .”
Yin, C., Tang, X., Zeng, J., Wang, Z., Mi, J., Liang, Y. J., Qin, D., Feng, Q., & Wu, A. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102954 · Cited by 15
Noel, R. L., Kugelman, T., Karakatsani, M. E., Shahriar, S., Willner, M. J., Jimenez, D. A., Choi, C. S., Niimi, Y., Ji, R., Agalliu, D., et al. (2026) · Communications Engineering · doi:10.1038/s44172-026-00597-5 · Cited by 22
Tissue-resident macrophages: from zebrafish to mouse
Lin, X., Wen, Z., & Xu, J. (2019) · Blood Science · doi:10.1097/bs9.0000000000000013 · Cited by 10
Wang, M., Jiang, Y., & Huang, Z. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00796-4 · Cited by 10
The Implication of Glial Metabotropic Glutamate Receptors in Alzheimer’s Disease
de Lima, I. B. Q., & Ribeiro, F. M. (2021) · Current Neuropharmacology · doi:10.2174/1570159x20666211223140303 · Cited by 10
Jensen, R. K., Pedersen, H., Lorentzen, J., Laursen, N. S., Vorup‐Jensen, T., & Andersen, G. R. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102168 · Cited by 14
“In vivo studies leave no doubt about the importance of the αMβ2 as a protective agent against infection (42) and as an aggravating factor in diseases with a poorly regulated inflammatory response, for instance, as observed in animal models of multiple sclerosis and Alzheimer’s disease (43).”
BackgroundCochlear resident macrophage mediates development of ribbon synapses via CX3CR1/CX3CL1 axis
Song, X., Li, Y., Guo, R., Yu, Q., Liu, S., Teng, Q., Chen, Z.-R., Xie, J., Gong, S., & Liu, K. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1031278 · Cited by 12
Fouad, G. I., & Ahmed, K. A. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110125 · Cited by 10
Lin, D., Sun, Y., Wang, Y., Yang, D., Shui, M., Wang, Y., Xue, Z., Huang, X. D., Zhang, Y., Wu, A., et al. (2023) · Neurochemical Research · doi:10.1007/s11064-023-03994-w · Cited by 10
Zhu, J., Jiang, X., Chang, Y., Wu, Y., Sun, S., Wang, C., Zheng, S., Wang, M., Yao, Y., Li, G., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110649 · Cited by 9
Unveiling the Molecular Footprint: Proteome-Based Biomarkers for Alzheimer’s Disease
Jain, M., Dhariwal, R., Patil, N., Ojha, S., Tendulkar, R., Tendulkar, M., Dhanda, P. S., Yadav, A., & Kaushik, P. (2023) · Proteomes · doi:10.3390/proteomes11040033 · Cited by 13
“Research suggests that the mitochondrial changes in the serum, CSF, and cortex are highly responsible for AD as supported by sufficient experimental evidence [167].”
BackgroundIyer, A. K., Schoch, K. M., Verbeck, A. C., Galasso, G., Chen, H., Smith, S. E., Oldenborg, A., Miller, T. M., Karch, C. M. M., & Bonni, A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0294731 · Cited by 9
Periodontitis and Alzheimer’s Disease: Is There a Connection?
Lundergan, W. P., Parthasarathy, K., & Knight, N. N. (2024) · Oral · doi:10.3390/oral4010006 · Cited by 9
“Using mouse models, it was demonstrated that microglia and complement can mediate early synapse loss in Alzheimer’s disease [38].”
Method
Metadata
- Authors
- Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., Lemere, C. A., Selkoe, D. J., & Stevens, B.
- Affiliations
- Boston Children's Hospital (US)
- Brigham and Women's Hospital (US)
- University of California, San Francisco (US)
- Stanford Medicine (US)
- Broad Institute (US)
- Corresponding author
- Beja-Glasser, Victoria F.
- Nfonoyim, Bianca M.
- Stevens, Beth
- ORCID
- Venue
- Science
- Published
- 2016-05-06
- Volume
- 352
- Issue
- 6286
- Pages
- 712-716
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5094372
- OpenAlex
- W2314634699
- Cited by
- 3,343
- References
- 33
- Citations by year
- 2026: 415 · 2025: 391 · 2024: 384 · 2023: 388 · 2022: 324 · 2021: 363 · 2020: 306 · 2019: 260 · 2018: 240 · 2017: 198 · 2016: 69
- FWCI
- 140.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Edward R. and Anne G. Lefler Fellowship
- Coins for Alzheimer's Research Trust
- Fidelity Biosciences Research Initiative
- JPB Foundation
- National Institutes of Health (AG000222)
- National Institute of Neurological Disorders and Stroke-NIH (R01NS083845)
- National Institute on Aging-NIH (1RF1AG051496A)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Alzheimer's disease, synaptic loss, complement system, microglia, C1q, CR3, complement C3, soluble amyloid-beta oligomers, neuroinflammation, synaptic pruning, hippocampal long-term potentiation, phagocytosis, mouse model
- MeSH terms
- Disks Large Homolog 4 Protein, Alzheimer Disease, Animals, Cognition Disorders, Complement Pathway, Classical, Disease Models, Animal, Membrane Proteins, Phagocytosis, Synapses, Up-Regulation, Complement C1q, Macrophage-1 Antigen, Amyloid beta-Peptides, Synaptophysin, Microglia, Long-Term Potentiation, Mice, Knockout, Mice, Guanylate Kinases, CA1 Region, Hippocampal, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.